Annual EPS
$0.02
-$1.02-98.08%
31 December 2023
Summary:
Supernus Pharmaceuticals annual earnings per share is currently $0.02, with the most recent change of -$1.02 (-98.08%) on 31 December 2023. During the last 3 years, it has fallen by -$2.34 (-99.15%). SUPN annual EPS is now -99.45% below its all-time high of $3.64, reached on 31 December 2011.SUPN EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EPS
$0.69
+$0.33+91.67%
30 September 2024
Summary:
Supernus Pharmaceuticals quarterly earnings per share is currently $0.69, with the most recent change of +$0.33 (+91.67%) on 30 September 2024. Over the past year, it has increased by +$0.98 (+337.93%). SUPN quarterly EPS is now -88.21% below its all-time high of $5.85, reached on 31 December 2011.SUPN Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EPS
$1.07
+$0.98+1093.75%
30 September 2024
Summary:
Supernus Pharmaceuticals TTM earnings per share is currently $1.07, with the most recent change of +$0.98 (+1093.75%) on 30 September 2024. Over the past year, it has increased by +$0.66 (+160.88%). SUPN TTM EPS is now -74.96% below its all-time high of $4.27, reached on 30 September 2012.SUPN TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SUPN EPS Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -98.1% | +337.9% | +160.9% |
| 3 y3 years | -99.2% | +72.5% | -29.2% |
| 5 y5 years | -99.0% | +27.8% | -45.7% |
SUPN EPS High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -99.2% | at low | at high | +337.9% | -29.2% | +468.3% |
| 5 y | 5 years | -99.2% | at low | -6.8% | +337.9% | -55.6% | +468.3% |
| alltime | all time | -99.5% | +100.7% | -88.2% | +110.4% | -75.0% | +108.0% |
Supernus Pharmaceuticals EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $0.69(+91.7%) | $1.07(+1093.8%) |
| June 2024 | - | $0.36(>+9900.0%) | $0.09(-130.9%) |
| Mar 2024 | - | $0.00(-87.4%) | -$0.29(>+9900.0%) |
| Dec 2023 | $0.02(-98.1%) | $0.02(-106.0%) | -$0.00(-100.6%) |
| Sept 2023 | - | -$0.29(+1350.0%) | $0.41(-43.8%) |
| June 2023 | - | -$0.02(-106.9%) | $0.73(-18.0%) |
| Mar 2023 | - | $0.29(-32.6%) | $0.89(-13.6%) |
| Dec 2022 | $1.04(+6.1%) | $0.43(+1333.3%) | $1.03(+60.9%) |
| Sept 2022 | - | $0.03(-78.6%) | $0.64(-36.6%) |
| June 2022 | - | $0.14(-67.4%) | $1.01(-22.3%) |
| Mar 2022 | - | $0.43(+975.0%) | $1.30(+32.7%) |
| Dec 2021 | $0.98(-58.5%) | $0.04(-90.0%) | $0.98(-35.1%) |
| Sept 2021 | - | $0.40(-7.0%) | $1.51(-18.4%) |
| June 2021 | - | $0.43(+290.9%) | $1.85(-10.6%) |
| Mar 2021 | - | $0.11(-80.7%) | $2.07(-12.3%) |
| Dec 2020 | $2.36(+12.4%) | $0.57(-23.0%) | $2.36(-2.1%) |
| Sept 2020 | - | $0.74(+13.8%) | $2.41(+9.0%) |
| June 2020 | - | $0.65(+62.5%) | $2.21(+1.8%) |
| Mar 2020 | - | $0.40(-35.5%) | $2.17(+2.8%) |
| Dec 2019 | $2.10(+2.4%) | $0.62(+14.8%) | $2.11(+7.1%) |
| Sept 2019 | - | $0.54(-11.5%) | $1.97(+1.0%) |
| June 2019 | - | $0.61(+79.4%) | $1.95(+2.1%) |
| Mar 2019 | - | $0.34(-29.2%) | $1.91(-7.3%) |
| Dec 2018 | $2.05(+89.8%) | $0.48(-7.7%) | $2.06(+12.0%) |
| Sept 2018 | - | $0.52(-8.8%) | $1.84(+14.3%) |
| June 2018 | - | $0.57(+16.3%) | $1.61(+18.4%) |
| Mar 2018 | - | $0.49(+88.5%) | $1.36(+28.3%) |
| Dec 2017 | $1.08 | $0.26(-10.3%) | $1.06(0.0%) |
| Sept 2017 | - | $0.29(-9.4%) | $1.06(-45.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2017 | - | $0.32(+68.4%) | $1.95(+7.7%) |
| Mar 2017 | - | $0.19(-26.9%) | $1.81(+6.5%) |
| Dec 2016 | $1.76(+528.6%) | $0.26(-78.0%) | $1.70(+7.6%) |
| Sept 2016 | - | $1.18(+555.6%) | $1.58(+229.2%) |
| June 2016 | - | $0.18(+125.0%) | $0.48(+41.2%) |
| Mar 2016 | - | $0.08(-42.9%) | $0.34(+21.4%) |
| Dec 2015 | $0.28(-207.7%) | $0.14(+75.0%) | $0.28(+16.7%) |
| Sept 2015 | - | $0.08(+100.0%) | $0.24(+140.0%) |
| June 2015 | - | $0.04(+100.0%) | $0.10(-28.6%) |
| Mar 2015 | - | $0.02(-80.0%) | $0.14(-153.8%) |
| Dec 2014 | -$0.26(-91.0%) | $0.10(-266.7%) | -$0.26(-74.3%) |
| Sept 2014 | - | -$0.06(-175.0%) | -$1.01(-41.6%) |
| June 2014 | - | $0.08(-121.1%) | -$1.73(-35.9%) |
| Mar 2014 | - | -$0.38(-41.5%) | -$2.70(-7.5%) |
| Dec 2013 | -$2.90(+6.6%) | -$0.65(-16.7%) | -$2.92(+5.0%) |
| Sept 2013 | - | -$0.78(-12.4%) | -$2.78(+9.0%) |
| June 2013 | - | -$0.89(+48.3%) | -$2.55(+12.3%) |
| Mar 2013 | - | -$0.60(+17.6%) | -$2.27(+8.4%) |
| Dec 2012 | -$2.72(-174.8%) | -$0.51(-7.3%) | -$2.09(-149.0%) |
| Sept 2012 | - | -$0.55(-9.8%) | $4.27(-334.8%) |
| June 2012 | - | -$0.61(+43.9%) | -$1.82(-71.5%) |
| Mar 2012 | - | -$0.42(-107.2%) | -$6.38(-6.4%) |
| Dec 2011 | $3.64(-220.3%) | $5.85(-188.2%) | -$6.81(-49.0%) |
| Sept 2011 | - | -$6.64(+28.4%) | -$13.35(+99.0%) |
| June 2011 | - | -$5.17(+501.6%) | -$6.71(+335.7%) |
| Mar 2011 | - | -$0.86(+26.3%) | -$1.54(+126.3%) |
| Dec 2010 | -$3.02(+1310.3%) | -$0.68(+4.2%) | -$0.68(+4.2%) |
| Dec 2009 | -$0.21(-92.0%) | -$0.65 | -$0.65 |
| Dec 2008 | -$2.66(+78.3%) | - | - |
| Dec 2007 | -$1.49 | - | - |
FAQ
- What is Supernus Pharmaceuticals annual earnings per share?
- What is the all time high annual EPS for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals annual EPS year-on-year change?
- What is Supernus Pharmaceuticals quarterly earnings per share?
- What is the all time high quarterly EPS for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals quarterly EPS year-on-year change?
- What is Supernus Pharmaceuticals TTM earnings per share?
- What is the all time high TTM EPS for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals TTM EPS year-on-year change?
What is Supernus Pharmaceuticals annual earnings per share?
The current annual EPS of SUPN is $0.02
What is the all time high annual EPS for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high annual earnings per share is $3.64
What is Supernus Pharmaceuticals annual EPS year-on-year change?
Over the past year, SUPN annual earnings per share has changed by -$1.02 (-98.08%)
What is Supernus Pharmaceuticals quarterly earnings per share?
The current quarterly EPS of SUPN is $0.69
What is the all time high quarterly EPS for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high quarterly earnings per share is $5.85
What is Supernus Pharmaceuticals quarterly EPS year-on-year change?
Over the past year, SUPN quarterly earnings per share has changed by +$0.98 (+337.93%)
What is Supernus Pharmaceuticals TTM earnings per share?
The current TTM EPS of SUPN is $1.07
What is the all time high TTM EPS for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high TTM earnings per share is $4.27
What is Supernus Pharmaceuticals TTM EPS year-on-year change?
Over the past year, SUPN TTM earnings per share has changed by +$0.66 (+160.88%)